Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Compare the loci-specific histone acetylation on the chromatin of FK228 and Class I HDACs YF mutants overexpression

ABSTRACT: To compare the H3K27ac effects of FK228 and Class I HDACs YF mutants overexpression and to characterize their inter-dependency, we performed ChIP-seq in AML12 cells in the above-mentioned 4 groups: control, FK228, YF overexpression, and FK228 + YF overexpression.

ORGANISM(S): Mus musculus

PROVIDER: GSE276219 | GEO | 2026/03/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Compare the transcriptomic effects of FK228 and Class I HDACs YF mutants overexpression

Project description:To compare the transcriptomic effects of FK228 and Class I HDACs YF mutants overexpression and to characterize their inter-dependency, we performed RNA-seq in AML12 cells in the above-mentioned 4 groups: control, FK228, YF overexpression, and FK228 + YF overexpression.

2026-03-28 | GSE276094 | GEO

Compare the transcriptomic effects of FK228 and Class I HDACs YF mutants overexpression

Project description:Compare the transcriptomic effects of FK228 and Class I HDACs YF mutants overexpression

| PRJNA1154675 | ENA

Compare the loci-specific histone acetylation on the chromatin of FK228 and Class I HDACs YF mutants overexpression

Project description:Compare the loci-specific histone acetylation on the chromatin of FK228 and Class I HDACs YF mutants overexpression

| PRJNA1156000 | ENA

Project description:yf Raw sequence reads

| PRJNA894515 | ENA

Influence of catalytic and non-catalytic functions of class I HDACs on the cellular transcriptome

Project description:We generated a cellular class I HDAC toolbox allowing to discriminate between catalytic and non-catalytic roles of class I HDACs. Our study reveals a comprehensive, functional analysis of class I HDACs.

2022-08-14 | GSE193885 | GEO

Gene expression profiles of HCT116 colorectal carcinoma cells treated with HDAC inhibitors

Project description:Histone deacetylases (HDACs) regulate gene expression. Inhibition of class I HDACs has been shown to inhibit cancer cell growth. Largazole, a new potent HDAC inhibitor, shows strong antitumor activity, presumably by modulating transcription of cancer relevant genes. We used microarray analysis of human HCT116 colorectal carcinoma cell line to determine the gene expression profile after largazole treatment in comparison with other HDAC inhibitors (FK228 and SAHA). The goal was to identify regulated genes that can be linked to the antiproliferative effects of these HDAC inhibitors in HCT116 cells. To characterize the genes regulated by Largazole, SAHA and FK228, genome-wide gene expression analysis was carried out. Human HCT116 colorectal carcinoma cells (400,000) were seeded per well (6-well dish) and one day later treated with Largazole, SAHA, FK228 and vehicle control. 10 h later, total RNA was extracted and processed for hybridization to an Affymetrix Human Genome U133 2.0 GeneChip. Global alterations in transcript levels upon Largazole, SAHA and FK228 treatment were determined through comparison with data derived from cells treated with vehicle control. The experiment was carried out in duplicate.

2010-08-28 | E-GEOD-22061 | biostudies-arrayexpress

Paenibacillus polymyxa strain:YF

Project description:Paenibacillus polymyxa strain:YF Genome

| PRJNA1215726 | ENA

Geobacillus sp. YF-1

Project description:Geobacillus sp. YF-1 Genome sequencing

| PRJNA1308053 | ENA

Histone deacetylase enzyme activity is not the universal anti-cancer target of HDAC inhibitors [RNA-seq_MC38]

Project description:As a family of anti-cancer drugs, histone deacetylase inhibitors (HDIs) show efficacies against a wide range of cancers, but their mechanism of action is unclear. Here, we performed unbiased bioinformatics analysis and found that genetic variants or expression levels of HDACs do not correlate with the carcinogenesis of most cancer types and do not predict cancer patient survival. Whole-genome CRISPR library screens did not identify HDACs as genes affecting cellular responses to HDIs such as SAHA or MS-275. Overexpression of dominant-negative, catalytically inactive Class I HDACs (HDAC1, 2, 3, and 8) caused a similar degree of histone hyperacetylation as Class I-specific HDI FK228 in cancer cell lines without similar anti-cancer effects, transcriptomic changes, or cellular responses to FK228. The anti-cancer effects of FK228 can be further dissociated from the histone hyperacetylation in an in-situ liver cancer mouse model. Importantly, chemical manipulations of several pan-HDIs abolished HDAC-inhibiting activity but retained the majority of anti-cancer effects in a mouse xenograft cancer model. These results suggest that HDAC enzyme activity is not a universal de facto target of HDIs for their anti-cancer efficacy. These findings have profound implications for understanding the pharmacodynamics of HDIs and developing next-generation compounds for this promising family of anti-cancer drugs.

2026-03-27 | GSE288240 | GEO

Escherichia coli strain:YF-1

Project description:Escherichia coli:YF-1 Genome sequencing

| PRJNA1134409 | ENA